Cargando…

Analysis of Human Performance Deficiencies Associated With Surgical Adverse Events

IMPORTANCE: Potentially preventable adverse events remain a formidable cause of patient harm and health care expenditure despite advances in systems-based risk-reduction strategies. OBJECTIVE: To analyze and describe the incidence of human performance deficiencies (HPDs) during the provision of surg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suliburk, James W., Buck, Quentin M., Pirko, Chris J., Massarweh, Nader N., Barshes, Neal R., Singh, Hardeep, Rosengart, Todd K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669897/ https://www.ncbi.nlm.nih.gov/pubmed/31365107 http://dx.doi.org/10.1001/jamanetworkopen.2019.8067

Ejemplares similares

Long-Term Wound Palliation to Manage Exposed Hardware in the Setting of Peripheral Arterial Disease
por: Zamani, Nader, et al.
Publicado: (2019)

Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States
por: Bykov, Katsiaryna, et al.
Publicado: (2020)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Association of Surgical Treatment With Adverse Events and Mortality Among Medicare Beneficiaries With Proximal Humerus Fracture
por: Floyd, Sarah B., et al.
Publicado: (2020)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

Nascent Medical Therapies for Abdominal Aneurysms
por: Barshes, Neal R.
Publicado: (2018)

Effect of an Electronic Medication Reconciliation Intervention on Adverse Drug Events: A Cluster Randomized Trial
por: Tamblyn, Robyn, et al.
Publicado: (2019)

Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients
por: Antonio, João Roberto, et al.
Publicado: (2016)

Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer
por: Meng, Lingbin, et al.
Publicado: (2023)

Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children
por: Yao, Tsung-Chieh, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
por: Najjar, Mimi, et al.
Publicado: (2023)

Consensus on surgical aspects of managing osteomyelitis in the diabetic foot
por: Allahabadi, Sachin, et al.
Publicado: (2016)

Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults
por: McAtee, Casey Lee, et al.
Publicado: (2021)

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022)

Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real‐world evidence study
por: Chen, Guanmin, et al.
Publicado: (2021)

Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction
por: Çetinkal, Gökhan, et al.
Publicado: (2018)

Testing Practices, Interpretation, and Diagnostic Evaluation of Iron Deficiency Anemia by US Primary Care Physicians
por: Read, Andrew J., et al.
Publicado: (2021)

Major adverse cardiac events and drug-coated balloon size in coronary interventions
por: Naguib, David, et al.
Publicado: (2018)

Order Substitutions and Education for Balanced Crystalloid Solution Use in an Integrated Health Care System and Association With Major Adverse Kidney Events
por: Bledsoe, Joseph, et al.
Publicado: (2022)

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
Publicado: (2016)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
por: Sonawane, Kalyani, et al.
Publicado: (2021)

Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review
por: Conti, Valeria, et al.
Publicado: (2022)

Association of Opioid Consumption Profiles After Hospitalization With Risk of Adverse Health Care Events
por: Kurteva, Siyana, et al.
Publicado: (2021)

Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis
por: Fazlollahi, Asra, et al.
Publicado: (2023)

Automated Electronic Frailty Index–Identified Frailty Status and Associated Postsurgical Adverse Events
por: Khanna, Ashish K., et al.
Publicado: (2023)

Improving Safety Recommendations Before Implementation: A Simulation-Based Event Analysis to Optimize Interventions Designed to Prevent Recurrence of Adverse Events
por: Langevin, Mélissa, et al.
Publicado: (2022)

CORRECTING GLUTATHIONE DEFICIENCY REVERSES MITOCHONDRIAL DYSFUNCTION AND ACCELERATED AGING IN PATIENTS WITH HIV
por: Sekhar, Rajagopal V, et al.
Publicado: (2019)

Adverse Events and Patient Outcomes Among Hospitalized Children Cared for by General Pediatricians vs Hospitalists
por: Atkinson, Mariam Krikorian, et al.
Publicado: (2018)

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis
por: Mincu, Raluca I., et al.
Publicado: (2019)

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
por: Wang, Le, et al.
Publicado: (2020)

Derivation of Patient-Defined Adverse Cardiovascular and Noncardiovascular Events Through a Modified Delphi Process
por: Sun, Louise Y., et al.
Publicado: (2021)

Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis
por: Farooq, Muhammad Zain, et al.
Publicado: (2022)

Adverse Events and Hospital-Acquired Conditions Associated With Potential Low-Value Care in Medicare Beneficiaries
por: Chalmers, Kelsey, et al.
Publicado: (2021)

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021)

Comparison of Adverse Events Among Home- vs Facility-Administered Biologic Infusions, 2007-2017
por: Baker, Matthew C., et al.
Publicado: (2021)

Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults
por: Schonfeld, Sara J., et al.
Publicado: (2022)

Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions
por: Arastu, Asad H., et al.
Publicado: (2022)

Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures
por: Butler, Anne M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h8ird8he8j3qqndrladikqqgol